High caseload of Scabies amongst Rohingya refugees in Cox's Bazar, Bangladesh: A retrospective analysis of the epidemiological and clinical characteristics of cases, July 2022 to November 2023
- PMID: 40202968
- PMCID: PMC11981167
- DOI: 10.1371/journal.pgph.0003981
High caseload of Scabies amongst Rohingya refugees in Cox's Bazar, Bangladesh: A retrospective analysis of the epidemiological and clinical characteristics of cases, July 2022 to November 2023
Abstract
Scabies is a dermatological parasitic infestation prevalent in many regions worldwide. Classified as a neglected disease by World Health Organization (WHO) since 2017, it is often associated with poor living conditions and overcrowding. Towards the end of 2021, unusual high numbers of scabies cases in outpatient consultations were observed in two Médecins Sans Frontières' (MSF) Primary Healthcare Centers (PHCs) in Rohingya refugee camps in Cox's Bazar, Bangladesh. Here, we aimed to describe the epidemiological and clinical characteristics of patients with scabies consulting the clinics from July 2022-November 2023. A cross-sectional study using routinely collected data from scabies' consultations at two MSF clinics located in camp 14 and 15 (total population 91,241 in 2023) was conducted. We retrospectively analyzed programmatic data of patients of all ages attending outpatient consultations and clinically diagnosed as scabies. Data were extracted from MSF clinical routine monitoring databases and descriptive statistics were reported. During the 16-month period, a total of 178,922 scabies consultations were recorded, amongst whom 57.7% were women and 42.3% men. Children <5 years constituted 20.5% of the cases, age-groups 6-14, 36.6%, and ≥15 years, 42.9%. Camp 15 had the highest number of cases (39.4%), followed by other camps (29.7%), and then camp 14 (24.4%). Most cases were simple scabies (79.5%); one in five were scabies with secondary infection cases. Patients were mainly treated with oral ivermectin (71.2%) and topical permethrin (24.3%); 19.5% of patients also received antibiotics. Our findings indicate that scabies is a significant health concern in the Cox's Bazar refugee camp. This study recorded over 178000 cases in the above period. The scale of this outbreak warrants further actions, including a prevalence survey, quality implementation of mass drug administration, and multidisciplinary interventions related to camps' living conditions such as water and sanitation.
Copyright: © 2025 Alhaffar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Assessment of water, sanitation and hygiene services within nineteen Rohingya camps in Cox's Bazar, Bangladesh in 2022.BMC Health Serv Res. 2025 Jun 9;25(1):814. doi: 10.1186/s12913-025-12874-8. BMC Health Serv Res. 2025. PMID: 40484924 Free PMC article.
-
"I don't want my marriage to end": a qualitative investigation of the sociocultural factors influencing contraceptive use among married Rohingya women residing in refugee camps in Bangladesh.Reprod Health. 2024 Mar 7;21(1):32. doi: 10.1186/s12978-024-01763-8. Reprod Health. 2024. PMID: 38454434 Free PMC article.
-
Oral Health of Rohingya Refugees Accessing Emergency Dental Care in the Refugee Camp in Cox's Bazar, Bangladesh.Community Dent Oral Epidemiol. 2025 Jun 10. doi: 10.1111/cdoe.13050. Online ahead of print. Community Dent Oral Epidemiol. 2025. PMID: 40495347
-
Trapped in Statelessness: Rohingya Refugees in Bangladesh.Int J Environ Res Public Health. 2017 Aug 21;14(8):942. doi: 10.3390/ijerph14080942. Int J Environ Res Public Health. 2017. PMID: 28825673 Free PMC article. Review.
-
Implementation and Delivery of Oral Cholera Vaccination Campaigns in Humanitarian Crisis Settings among Rohingya Myanmar nationals in Cox's Bazar, Bangladesh.Vaccines (Basel). 2023 Apr 14;11(4):843. doi: 10.3390/vaccines11040843. Vaccines (Basel). 2023. PMID: 37112756 Free PMC article. Review.
References
-
- WHO. Scabies. [cited 26 Jun 2024]. Available: https://www.who.int/news-room/fact-sheets/detail/scabies
-
- CDC. About Scabies. In: Scabies [Internet]. 23 Feb 2024. [cited 20 Aug 2024]. Available: https://www.cdc.gov/scabies/about/index.html.
LinkOut - more resources
Full Text Sources
Miscellaneous